Apg Asset Management N.V. Ionis Pharmaceuticals Inc Transaction History

Apg Asset Management N.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $945,828 - $1.14 Million	-28,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $974,028 - $1.33 Million	28,200 New	28,200 $949,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $8.58 Million - $11.2 Million	-183,160 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $7.62 Million - $11.6 Million	183,160 New	183,160 $8.66 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $9.48 Million - $14.5 Million	-228,001 Closed	0 $0

Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $23.8 Million - $28.8 Million	-441,686 Reduced 65.95%	228,001 $12.3 Million
Q3 2019 Nov 08, 2019	BUY	$59.06 - $72.15 $28.1 Million - $34.3 Million	476,087 Added 245.91%	669,687 $36.8 Million
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $12 Million - $16.7 Million	193,600 New	193,600 $10.9 Million

397

122M

854K

464K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.